2022
DOI: 10.1039/d2fo01424f
|View full text |Cite
|
Sign up to set email alerts
|

Targeted metabolomics combined with network pharmacology to reveal the protective role of luteolin in pulmonary arterial hypertension

Abstract: Luteolin protects from PAH by affecting metabolites and regulatory enzymes’ gene and protein levels in the arachidonic acid pathway.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(1 citation statement)
references
References 38 publications
0
1
0
Order By: Relevance
“…Treatment with luteolin, a dietary supplement, returned the altered arachidonic acid, amino acids, and tricarboxylic acid cycle levels close to normal. Luteolin partially reversed the adverse pulmonary vascular remodeling in PAH rats by blocking the excessive and rapid increase in the number of pulmonary artery smooth muscle cells [58].…”
Section: Pah Pathogenesismentioning
confidence: 93%
“…Treatment with luteolin, a dietary supplement, returned the altered arachidonic acid, amino acids, and tricarboxylic acid cycle levels close to normal. Luteolin partially reversed the adverse pulmonary vascular remodeling in PAH rats by blocking the excessive and rapid increase in the number of pulmonary artery smooth muscle cells [58].…”
Section: Pah Pathogenesismentioning
confidence: 93%